Vestmark Advisory Solutions, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Vestmark Advisory Solutions, Inc.

  • $3.54 Billion
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$42.07 - $57.72 $28,102 - $38,556
-668 Reduced 11.24%
5,277 $222,000
Q2 2024

Aug 12, 2024
BUY
$37.42 - $51.61 $222,461 - $306,821
5,945 New
5,945 $244,000
Q2 2021

Aug 09, 2021
SELL
$92.19 - $115.71 $207,427 - $260,347
-2,250 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$106.9 - $167.73 $240,525 - $377,392
2,250 New
2,250 $256,000

Others Institutions Holding RARE

# of Institutions
336
Shares Held
88.9M
Call Options Held
1.08M
Put Options Held
1.04M
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.5B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email